IPCA Laboratories Limited — Important, 05-02-2025: General Updates

The company has received a substantial demand from the Additional Commissioner under the CGST Act, amounting to ₹1.71 crore plus penalty and interest for the fiscal years 2017-18 through 2021-22. Despite this tax demand, the company assesses that there is no material impact on its financials or operations. It considers the demand to be legally untenable and plans to appeal the order within the required timeframe. Investors should stay informed about this situation as it could affect the company's operational outlook.